Background: ETFDH (electron-transferring-flavoprotein dehydrogenase), also known as electron transfer flavoprotein-ubiquinone oxidoreductase, MADD or ETFQO, is a 617 amino acid membrane-bound electron transfer protein that exists as a monomer, localizes to the mitochondrial inner membrane and belongs to the ETF-QO/fixC family. ETFDH accepts electrons from electron-transfer flavoprotein (ETF) in the mitochondrial matrix while reducing ubiquinone in the mitochondrial membrane. ETFDH is encoded by a gene mapping to human chromosome 4q32.1, and contains one molecule of FAD and a 4Fe-4S cluster. As a result of alternative splicing events, two ETFDH isoforms exist. Defects in ETFDH are responsible for an autosomal recessive disorder of amino acid, fatty acid and choline metabolism known as glutaric aciduria type 2C (GA2C) or multiple acyl-CoA dehydrogenation deficiency (MADD). GA2C is characterized by severe hypoketotic hypoglycemia and acidosis.

Description: Rabbit polyclonal to ETFDH

Immunogen: KLH conjugated synthetic peptide derived from ETFDH

Specificity:  ·Reacts with Human, Mouse, Dog and Rat.

·Isotype: IgG

Application:  ·Western blotting: 1/100-500. Predicted Mol wt: 69 kDa;

·Immunohistochemistry (Paraffin/frozen tissue section): 1/50-200;

·Immunocytochemistry/Immunofluorescence: 1/100;

·Immunoprecipitation: 1/50;

·ELISA: 1/500;

·Optimal working dilutions must be determined by the end user.